Montelukast Drug Market Report – Research, Industry Analysis Reports and Market Demands

Global (United States, European Union and China) Montelukast Drug Market Research Report 2019-2025

Request for Sample of this report

Buy now

Table of Content

1 Report Overview

1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
- 1.3.1 Global Montelukast Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Tablet
- 1.3.3 Chewable tablet
- 1.3.4 Oral Granules
1.4 Market Segment by Application
- 1.4.1 Global Montelukast Drug Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Drug store
- 1.4.4 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends

2.1 Global Montelukast Drug Market Size
- 2.1.1 Global Montelukast Drug Revenue 2014-2025
- 2.1.2 Global Montelukast Drug Sales 2014-2025
2.2 Montelukast Drug Growth Rate by Regions
- 2.2.1 Global Montelukast Drug Sales by Regions 2014-2019
- 2.2.2 Global Montelukast Drug Revenue by Regions 2014-2019
2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers

3 Market Share by Manufacturers

3.1 Montelukast Drug Sales by Manufacturers
- 3.1.1 Montelukast Drug Sales by Manufacturers 2014-2019
- 3.1.2 Montelukast Drug Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
- 3.2.1 Montelukast Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Montelukast Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Montelukast Drug Market Concentration Ratio (CR5 and HHI)
3.3 Montelukast Drug Price by Manufacturers
3.4 Key Manufacturers Montelukast Drug Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Montelukast Drug Market
3.6 Key Manufacturers Montelukast Drug Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Sales and Revenue for Each Type
- 4.1.1 Tablet Sales and Revenue (2014-2019)
- 4.1.2 Chewable tablet Sales and Revenue (2014-2019)
- 4.1.3 Oral Granules Sales and Revenue (2014-2019)
4.2 Global Montelukast Drug Sales Market Share by Type
4.3 Global Montelukast Drug Revenue Market Share by Type
4.4 Montelukast Drug Price by Type

5 Market Size by Application

5.1 Overview
5.2 Global Montelukast Drug Sales by Application

6 United States

6.1 United States Montelukast Drug Breakdown Data by Company
6.2 United States Montelukast Drug Breakdown Data by Type
6.3 United States Montelukast Drug Breakdown Data by Application

7 European Union

7.1 European Union Montelukast Drug Breakdown Data by Company
7.2 European Union Montelukast Drug Breakdown Data by Type
7.3 European Union Montelukast Drug Breakdown Data by Application

8 China

8.1 China Montelukast Drug Breakdown Data by Company
8.2 China Montelukast Drug Breakdown Data by Type
8.3 China Montelukast Drug Breakdown Data by Application

9 Rest of World

9.1 Rest of World Montelukast Drug Breakdown Data by Company
9.2 Rest of World Montelukast Drug Breakdown Data by Type
9.3 Rest of World Montelukast Drug Breakdown Data by Application
9.4 Rest of World Montelukast Drug Breakdown Data by Countries
- 9.4.1 Rest of World Montelukast Drug Sales by Countries
- 9.4.2 Rest of World Montelukast Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia

10 Company Profiles

11 Value Chain and Sales Channels Analysis

11.1 Value Chain Analysis
11.2 Sales Channels Analysis
- 11.2.1 Montelukast Drug Sales Channels
- 11.2.2 Montelukast Drug Distributors
11.3 Montelukast Drug Customers

12 Market Forecast

12.1 Global Montelukast Drug Sales and Revenue Forecast 2019-2025
12.2 Global Montelukast Drug Sales Forecast by Type
12.3 Global Montelukast Drug Sales Forecast by Application
12.4 Montelukast Drug Forecast by Regions
- 12.4.1 Global Montelukast Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Montelukast Drug Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
  - 14.1.1.1 Research Programs/Design
  - 14.1.1.2 Market Size Estimation
  - 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
  - 14.1.2.1 Secondary Sources
  - 14.1.2.2 Primary Sources
14.2 Author Details

Description

Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.
In 2019, the market size of Montelukast Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Montelukast Drug.

This report studies the global market size of Montelukast Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Montelukast Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Merck & Co.
Teva
Mylan
Glenmark Pharmaceuticals
Hikma Group
Sandoz
Torrent Pharmaceuticals
Lannett Company
Apotex
Dr. Reddys Laboratories
Aurobindo Pharma
Accord Healthcare
Hetero
Unimark
Ajanta Pharma
MACLEODS
Jubilant Pharma
Unichem Laboratories
Amneal Pharmaceuticals
Shanghai Anbison Lab
Perrigo
Cipla
CSPC Ouyi Pharmaceutical

Market Segment by Product Type
Tablet
Chewable tablet
Oral Granules

Market Segment by Application
Hospital
Drug store
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Montelukast Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Montelukast Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Montelukast Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025